Add Formweb to your mobile device
Search results for:
HYDROmorphone
HYDROmorphone
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Dilaudid-5 | LIQUID, ORAL | 1 mg/mL | |
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 1 mg/mL | |
| Dilaudid | SOLUTION, INJECTABLE | 2 mg/mL | |
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 2 mg/mL | |
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 4 mg/mL | |
| Dilaudid-HP | SOLUTION, INJECTABLE | 10 mg/mL | |
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 10 mg/mL | |
| HYDROmorphone HCl | SUPPOSITORY, RECTAL | 3 mg | |
| HYDROmorphone HCl | TABLET, ORAL | 2 mg | |
| HYDROmorphone HCl | TABLET, ORAL | 4 mg |
DEA Class II VIEW MORE Opioid Agonists
Last updated: Apr. 28, 2026
- High Alert: CAUTION: See High-Alert Medication Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Do Not Crush: ER Tablet
- Black Box Warning: Respiratory depression risk; abuse potential
- REMS: Opioid Analgesic REMS-View FDA REMS Info
- REMS: Legacy Health REMS Requirements-Opioid Analgesics
Patient Controlled Analgesia (PCA): See Policy 900.4103
Hydromorphone may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)
The Opioid Analgesic REMS program includes health care provider and patient related requirements for prescribing, see Legacy Health REMS Requirements for detail.